Company: G
Filing Date: 2025-08-11
Form Type: 10-Q
Source: 0001398659-25-000098
Chunk: 38

Company: Genpact LTD
Filing Date: 2025-08-11
Form: 10-Q
Item: Part I, Item 1
Chunk 38
---
2,923 Net settlement on vesting of restricted share units (Note 15)20,047 — (375)— — (375)Net settlement on vesting of performance units (Note 15)Stock repurchased and retired (Note 16)(1,920,063)(19)— (62,626)— (62,645)Expenses and taxes related to stock repurchased (Note 16)— — — (239)— (239)Stock-based compensation expense (Note 15)— — 18,369 — — 18,369 Comprehensive income (loss): Net income (loss)— — — 121,990 — 121,990 Other comprehensive income (loss)— — — — (13,297)(13,297)Dividend ($0.1525 per common share, Note 16)— — — (27,337)— (27,337)Balance as of June 30, 2024178,177,581 $1,776 $1,900,015 $1,176,459 $(740,491)$2,337,759 

See accompanying notes to the Consolidated Financial Statements.

6

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Equity 

For the six months ended June 30, 2024

(Unaudited)

(In thousands, except share count)

 Common sharesAccumulated OtherComprehensiveIncome (Loss)No. ofSharesAmountAdditional Paid-in CapitalRetainedEarningsTotalEquityBalance as of January 1, 2024179,494,132 $1,789 $1,883,944 $1,085,209 $(722,550)$2,248,392 Issuance of common shares on exercise of options (Note 15)135,051 1 3,930 — — 3,931 Issuance of common shares under the employee stock purchase plan (Note 15)191,888 2 5,787 — — 5,789 Net settlement on vesting of restricted share units (Note 15)271,785 3 (4,283)— — (4,280)Net settlement on vesting of performance units (Note 15)869,713 9 (16,913)— —